Tandem Diabetes Care, Inc. (TNDM)
20.97
-0.48
(-2.24%)
USD |
NASDAQ |
Dec 11, 16:00
21.36
+0.39
(+1.86%)
After-Hours: 06:23
Tandem Diabetes Care Research and Development Expense (Quarterly): 47.88M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Insulet Corp. | 77.20M |
| Abbott Laboratories | 748.00M |
| Integra LifeSciences Holdings Corp. | 20.42M |
| Teleflex, Inc. | 57.23M |
| Perspective Therapeutics, Inc. | 19.56M |